Citation Impact
Citing Papers
Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders
2002
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
2009 Standout
Implication of the hypothalamic–pituitary–adrenal axis in the physiopathology of depression
2004
Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse
2009 Standout
Test-dependent changes in nociception after administration of the putative serotonin antagonist metitepin in mice
1987
Effects of 5-HT2 and 5-HT3 receptors on the modulation of nociceptive transmission in rat spinal cord according to the formalin test
2001
Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?
1995
Phencyclidine- and Dizocilpine-Induced Hyperlocomotion Are Differentially Mediated
1994
Descending control of pain
2002 Standout
Combined cholinergic and serotonergic denervation of the forebrain produces severe deficits in a spatial learning task in the rat
1988
Mechanisms of action of atypical antipsychotic drugs
1991
From Threat to Fear: The Neural Organization of Defensive Fear Systems in Humans
2009 StandoutNobel
Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence
1993 Standout
Cocaine self-administration in dopamine-transporter knockout mice
1998
Allelic Variation of Human Serotonin Transporter Gene Expression
1996 Standout
The selective dopamine antagonist properties of BRL 34778: a novel substituted benzamide
1988 StandoutNobel
Hippocampal type I and type II corticosteroid receptors are modulated by central noradrenergic systems
1992
Antinociceptive effects of acute and ‘chronic’ injections of tricyclic antidepressant drugs in a new model of mononeuropathy in rats
1992
Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients
1993
Atypical neuroleptics: role of multiple receptors, endogenous dopamine, and receptor linkage
1990
Partial dopamine receptor agonists reverse behavioral, biochemical and neuroendocrine effects of neuroleptics in the rat: Potential treatment of extrapyramidal side effects
1993 StandoutNobel
Neuroleptics increase C-FOS expression in the forebrain: Contrasting effects of haloperidol and clozapine
1992
A new wave of serotonin receptors
1993 StandoutNobel
Chronic Treatment of Rats with SCH‐23390 or Raclopride Does Not Affect the Concentrations of DARPP‐32 or Its mRNA in Dopamine‐Innervated Brain Regions
1990 StandoutNobel
Addiction Motivation Reformulated: An Affective Processing Model of Negative Reinforcement.
2004 Standout
Mice Deficient in Golf Are Anosmic
1998 StandoutNobel
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Differential actions of typical and atypical antipsychotic drugs on dopamine release in the core and shell of the nucleus accumbens
1996
Antagonistic interaction between adenosine A2A receptors and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia
1994
Adenosine A2A Agonists: A Potential New Type of Atypical Antipsychotic
1997
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment
2001
Synthesis and Release of Dopamine in Rat Brain: Comparison Between Substantia Nigra Pars Compacta, Pars Reticulata, and Striatum
1989 StandoutNobel
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Gut–brain axis: how the microbiome influences anxiety and depression
2013 Standout
Effect of Chronic Administration of Selective Glucocorticoid Receptor Antagonists on the Rat Hypothalamic–Pituitary–Adrenocortical Axis
2002
Stress and the brain: from adaptation to disease
2005 Standout
Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions
1991 Standout
Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats
1992
Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia
2000 Standout
The dopamine D3 receptor and autoreceptor preferring antagonists (+)-AJ76 and (+)-UH232; a microdialysis study
1993 StandoutNobel
The Psychopharmacology of 5‐HT3Receptors*
1992
The formalin test: an evaluation of the method
1992 Standout
Antidepressants and Hypothalamic-Pituitary-Adrenocortical Regulation
1996
The acute inhibition of rapid eye movement sleep by citalopram may impair spatial learning and passive avoidance in mice
2012
Steroid-Independent Translocation of the Glucocorticoid Receptor by the Antidepressant Desipramine
1997
Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications
1997 StandoutNobel
MK-801-induced hyperlocomotion: Differential effects of M100907, SDZ PSD 958 and raclopride
1997 StandoutNobel
Chronic administration of desipramine and zimelidine changes the behavioural response in the formalin test in rats
1991
Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety
1999 Standout
Glucocorticoids and the Genesis of Depressive Illness a Psychobiological Model
1994
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine
1991 StandoutNature
Neurocircuitry of Addiction
2009 Standout
Opioid-monoamine interactions in spinal antinociception: evidence for serotonin but not norepinephrine reciprocity
1988
Antinociceptive effect of ketanserin in mice: involvement of supraspinal 5-HT2 receptors in nociceptive transmission
1991
Antinociceptive effects of serotonergic reuptake inhibitors in mice
1989
Yawning induced by the selective dopamine D2 agonist N-0437 is blocked by the selective dopamine autoreceptor antagonist (+)-UH 232
1989
Dopamine receptor subtypes: beyond the D1/D2 classification
1990
Dopamine, learning and motivation
2004 Standout
Uropathic Observations in Mice Expressing a Constitutively Active Point Mutation in the 5-HT3AReceptor Subunit
2004 StandoutNobel
Autoradiographic mapping of 5-HT1, 5-HT1A, 5-HT1B and 5-HT2 receptors in the rat spinal cord
1991
The Role of 5–Hydroxytryptamine (5–HT) Receptor Subtypes and Plasticity in the 5–HT Systems in the Regulation of Nociceptive Sensitivity
1993
Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosineand dopamine-β-hydroxylase inhibitors
1972
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Reduced growth hormone releasing factor (GHRF)-like immunoreactivity and GHRF gene expression in the hypothalamus of aged rats
1989
5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system.
1989 StandoutNobel
Clonidine-induced locomotor hyperactivity in rats
1977
A parametric study of the effects of the noradrenaline neurotoxin DSP4 on avoidance acquisition and noradrenaline neurones in the CNS of the rat
1984
Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites
1986
Attenuation of morphine-induced analgesia by p-chlorophenylalanine and p-chloroamphetamine: Test-dependent effects and evidence for brainstem 5-hydroxytryptamine involvement
1983
5-HT and mechanisms of defence
1991
When Fear Is Near: Threat Imminence Elicits Prefrontal-Periaqueductal Gray Shifts in Humans
2007 StandoutScienceNobel
Nervous system distribution of the serotonin 5-HT3 receptor mRNA.
1993 StandoutNobel
Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors
1985 Standout
The pharmacological and anatomical substrates of the amphetamine response in the rat
1975
Evidence for a possible functional interaction between serotonergic and cholinergic mechanisms in memory retrieval
1987
Sulpiride and Haloperidol in Schizophrenia: A Double-blind Cross-over Study of Therapeutic Effect, Side Effects and Plasma Concentrations
1985
Effect of chronic antidepressant treatment and subsequent withdrawal on [3H]-5-hydroxytryptamine and [3H]-spiperone binding in rat frontal cortex and serotonin receptor mediated behaviour
1983
Selective lesions of the bulbospinal serotonergic pathways reduce the analygesia induced by p-chloroamphetamine in the hot-plate test
1984
Enhanced Rewarding Properties of Morphine, but not Cocaine, in βarrestin-2 Knock-Out Mice
2003 StandoutNobel
The relative importance of dopaminergic and noradrenergic neuronal systems for the stimulation of locomotor activity induced by amphetamine and other drugs
1973
The neuropsychology and neuropharmacology of the dorsal ascending noradrenergic bundle—a review
1980
Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system.
1993
Subjective well-being: Three decades of progress.
1999 Standout
Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum
1975 Standout
About Sleep's Role in Memory
2013 Standout
Changes in nociception after acute and chronic administration of zimelidine: Different effects in the formalin test and the substance p behavioural assay
1987
Dopamine D2 receptors and dopamine metabolismRelationship between biochemical and behavioural effects of substituted benzamide drugs
1986
Effects of Chronic Neuroleptic Treatment on Agonist Affinity States of the Dopamine‐D2receptor in the Rat Brain
1987
Précis ofThe neuropsychology of anxiety: An enquiry into the functions of the septo-hippocampal system
1982 Standout
A psychomotor stimulant theory of addiction.
1987 Standout
Brain Corticosteroid Receptor Balance in Health and Disease*
1998 Standout
Does dopamine play a role in schizophrenia?
1977 StandoutNobel
Specific in vitro and in vivo binding of 3H-raclopride a potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain
1985
Chronic antidepressant treatment and central 5-HT synapses
1983
Sulpiride versus Haloperidol, a Clinical Trial in Schizophrenia. A preliminary report
1984
Opioids, Reward and Addiction: An Encounter of Biology, Psychology, and Medicine
1999
Development of tolerance to the antinociceptive effect of metergoline
1987
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
2001 Standout
Antipsychotic Drugs, Neurotransmitters, and Schizophrenia
1978 StandoutNobel
Remoxipride, a new potential antipsychotic compound with selective anti-dopaminergic actions in the rat brain
1984
Nucleus locus ceruleus: new evidence of anatomical and physiological specificity
1983 Standout
Serotonin Uptake in Blood Platelets of Psychiatric Patients
1981
Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region
1996 StandoutScience
Amphetamine models of paranoid schizophrenia: An overview and elaboration of animal experimentation.
1980
AN INTEGRATIVE THEORY OF LOCUS COERULEUS-NOREPINEPHRINE FUNCTION: Adaptive Gain and Optimal Performance
2005 Standout
Serotonin receptor changes after chronic antidepressant treatments: Ligand binding, electrophysiological, and behavioral studies
1983
Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
1986 Standout
Tachykinins and calcitonin gene-related peptide enhance release of endogenous glutamate and aspartate from the rat spinal dorsal horn slice
1990
Lesions of the ascending serotonergic pathways and antinociceptive effects after systemic administration of p-chloroamphetamine in mice
1986
Dopamine Receptors: From Structure to Function
1998 Standout
Selective 60HDA-induced destruction of mesolimbic dopamine neurons: Abolition of psychostimulant-induced locomotor activity in rats
1976
Works of S. -O. �gren being referenced
Comparison of the effects of haloperidol, remoxipride and raclopride on ?pre?- and postsynaptic dopamine receptors in the rat brain
1988
Effects of acute and chronic treatment with imipramine on 5-hydroxytryptamine nerve cell groups and on bulbospinal 5-hydroxytryptamine/substance P/thyrotropin releasing hormone immunoreactive neurons in the rat. A morphometric and microdensitometric analysis
1987
Effects of chronic imipramine treatment on glucocorticoid receptor immunoreactivity in various regions of the rat brain
1988
Evidence for selective serotonergic receptor involvement in p-chloroamphetamine-induced antinociception
1985
DSP4-induced two-way active avoidance impairment in rats: Involvement of central and not peripheral noradrenaline depletion
1982
The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions
1986
Reevaluation of the indoleamine hypothesis of depression. Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs
1979
Alaproclate, a new selective 5-HT uptake inhibitor with therapeutic potential in depression and senile dementia
1984
Regional blockade by neuroleptic drugs ofin vivo 3H-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypies
1981
Separation of the associative and non-associative effects of brain serotonin released by p-chloroamphetamine: Dissociable serotoninergic involvement in avoidance learning, pain and motor function
1985
The effect of acute zimeldine and alaproclate administration on the acquisition of two-way active avoidance: Comparison with other antidepressant agents, test of selectivity and sub-chronic studies
1984
In vivo andin vitro studies on the potentiation of muscarinic receptor stimulation by alaproclate, a selective 5-HT uptake blocker
1985
Decreased morphine intake by opiate addicted rats administered zimelidine, a 5-HT uptake inhibitor
1983
Studies on the action of some psychoactive drugs on central noradrenaline neurones after inhibition of dopamine-β-hydroxylase
1970
Serotonin type-2 receptor mediated regulation of substance P release in the ventral spinal cord and the effects of chronic antidepressant treatment
1986
Test-specific effects of the 5-HT reuptake inhibitors alaproclate and zimelidine on pain sensitivity and morphine analgesia
1980